XJPX
4189
Market cap636mUSD
Jul 10, Last price
2,941.00JPY
1D
1.24%
1Q
0.96%
Jan 2017
139.11%
IPO
132.49%
Name
KH Neochem Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Operating both domestically in Japan and across global markets, KH Neochem Co., Ltd. specializes in the research, production, and distribution of a wide array of petrochemical goods. Their extensive product portfolio encompasses various chemical compounds, including alcohols, esters, ketones, glycol ethers, synthetic fatty acids, aldehydes, diols, hydrocarbons, and functional monomers. Among their offerings are fundamental chemical substances like butyl alcohol, butyl acetate, 2-ethylhexyl alcohol, and isononyl alcohol, which find application in manufacturing paints, inks, thinners, detergents, and serve as raw materials for plasticizers and resins. Furthermore, they supply high-performance materials such as 2-ethylhexanoic acid, isononanoic acid, diacetone acrylamide, and 1,3-butylene glycol, essential for products ranging from lubricants and water-based paints to cosmetics. The company's specialized electronic materials segment includes propylene glycol monomethyl ether acetate-P and propylene glycol monomethyl ether-P, vital components for the production of LCD panels and semiconductors. Established in 1966, KH Neochem Co., Ltd. maintains its corporate headquarters in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||